GeoVax Labs

GeoVax is a clinical-stage biotechnology company developing human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease
GeoVax Labs stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

GeoVax Labs balance sheet

Report period2018201920202021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

GeoVax Labs cash flows

Report period2018201920202021
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

GeoVax Labs multipliers

Report period2018201920202021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

GeoVax Labs profitability

Report period2018201920202021
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
GeoVax Labs assets
GeoVax Labs cash flows

GeoVax Labs dividend policy

The company does not pay dividends

GeoVax Labs shares

TickerNameTypeNominal valueISINPrice
GOVX:USGeoVax LabsCommon share-US3736785078$6.39
General information
Company nameGeoVax Labs
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address1900 LAKE PARK DRIVE, SUITE 380, SMYRNA, GA, 30080
Mailing address1900 LAKE PARK DRIVE, SUITE 380, SMYRNA, GA, 30080
Websitewww.geovax.com
Information disclosurewww.sec.gov